MEDICAL IMAGE DIAGNOSIS SYSTEM AND TISSUE CHARACTERISTIC ESTIMATION METHOD

1 . A medical image diagnosis system comprising:

an imaging apparatus configured to apply one-time or multiple-time medical imaging to a subject to which a plurality of drugs having a tissue accumulation property, which corresponds to a tissue characteristic, are administered successively or simultaneously; and

processing circuitry configured to:

reconstruct one or a plurality of medical images, based on one or a plurality of set of raw data acquired by the one-time or multiple-time medical imaging;

estimate a tissue characteristic of a target region included in the subject, based on a spatial distribution of the drugs rendered on the one or the plurality of medical images; and

display the estimated tissue characteristic on a display device.

2 . The medical image diagnosis system of claim 1 , wherein

the drugs have mutually different particle sizes, and

the processing circuitry estimates a progress degree of the target region as the tissue characteristic.

3 . The medical image diagnosis system of claim 2 , wherein the processing circuitry is configured to:

estimate that the progress degree is a first progress degree, in a case where only a drug of a first particle size, among the drugs, is distributed in the target region on the one or the plurality of medical images; and

estimate that the progress degree is a second progress degree that is more advanced than the first progress degree, in a case where a drug of a second particle size greater than the first particle size, among the drugs, is distributed in the target region on the one or the plurality of medical images.

4 . The medical image diagnosis system of claim 3 , wherein the processing circuitry estimates that the progress degree is a third progress degree that is less advanced than the first progress degree, in a case where each of the drug of the first particle size and the drug of the second particle size is distributed in the target region.

5 . The medical image diagnosis system of claim 2 , wherein the processing circuitry estimates the progress degree of the target region, based on a comparison between a spatial distribution of a drug of a specific particle size among the drugs on the medical image at a time when a vasodilator drug is not administered to the subject, and a spatial distribution of the drug of the specific particle size on a medical image at a time when the vasodilator drug is administered to the subject.

6 . The medical image diagnosis system of claim 1 , wherein

the drugs have mutually different tissue type sensitivities, and

the processing circuitry estimates a tissue type of the target region as the tissue characteristic.

7 . The medical image diagnosis system of claim 6 , wherein

a first drug among the drugs accumulates in tissues of a plurality of types,

a second drug among the drugs accumulates in a tissue of a specific type among the types, and

the processing circuitry estimates the tissue type as the tissue characteristic, based on a difference between a spatial distribution of the first drug rendered on a first medical image at a time when the first drug is administered to the subject, and a spatial distribution of the second drug rendered on a second medical image at a time when the second drug is administered to the subject.

8 . The medical image diagnosis system of claim 6 , wherein

the target region is a tumor, or a tissue that is suspected to be a tumor,

the tissue characteristic is a tumor type that means a progress degree or a type of a tumor,

the tissue accumulation property is a capability of accumulation of a drug in a tumor, and

the tumor type includes a primary focus and a metastasis focus.

9 . The medical image diagnosis system of claim 7 , wherein

the first drug is a contrast agent used in PET imaging that contrast-enhances the tissues of the plurality of types, and

the second drug is a contrast agent used in PCCT imaging that contrast-enhances the tissue of the specific type.

10 . The medical image diagnosis system of claim 7 , wherein

the target region is a tumor, or a tissue that is suspected to be a tumor,

the tissue characteristic is a tumor type that means a progress degree or a type of a tumor,

the tissue accumulation property is a capability of accumulation of a drug in a tumor,

the first drug includes an iodine preparation that contrast-enhances tumors of the plurality of types, and

the second drug includes an anticancer drug for a tumor of the specific type.

11 . The medical image diagnosis system of claim 1 , wherein

the plurality of drugs are labeled with mutually different high atomic number substances, and

the imaging apparatus executes, as the one-time or multiple-time medical imaging, K-edge imaging for targets that are the high atomic number substances included in the drugs.

12 . The medical image diagnosis system of claim 1 , wherein

the target region is a tumor, or a tissue that is suspected to be a tumor,

the tissue characteristic is a tumor type that means a progress degree or a type of a tumor, and

the tissue accumulation property is a capability of accumulation of a drug in a tumor.

13 . The medical image diagnosis system of claim 12 , wherein the processing circuitry estimates a TNM classification as the tumor characteristic.

14 . A medical image diagnosis method comprising:

applying one-time or multiple-time medical imaging to a subject to which a plurality of drugs having a tissue accumulation property, which corresponds to a tissue characteristic, are administered successively or simultaneously;

reconstructing one or a plurality of medical images, based on one or a plurality of set of raw data acquired by the one-time or multiple-time medical imaging;

estimating a tissue characteristic of a target region included in the subject, based on a spatial distribution of the drugs rendered on the one or the plurality of medical images; and

displaying the estimated tissue characteristic on a display device.